Results for untargeted MS search on m/z: (+/-) mode (maximum rows displayed:1000)
| Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| AN001423 | 56.0631 | 4.32 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 58.0421 | 3.81 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 59.0739 | 4.23 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 68.0625 | 3.95 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 68.0649 | 5.65 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 70.0420 | 4.04 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 71.0598 | 0.73 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 75.0325 | 4.32 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 80.0262 | 2.77 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 80.0627 | 19.96 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 82.0411 | 3.98 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 82.0421 | 4.13 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 82.0423 | 3.64 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 82.0787 | 7.6 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 84.0578 | 4.32 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 85.0538 | 1.09 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 85.0889 | 1.58 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 3-AMINOISOBUTYRIC ACID (M+H)+[-H2O] | 86.0600 | 1.83 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 90.0471 | 5.27 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 92.0479 | 5.47 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 93.0577 | 2.22 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 94.0053 | 2.77 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 94.0406 | 3.92 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 96.0578 | 7.06 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 96.0596 | 5.66 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 96.0640 | 8.39 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 96.0941 | 8.6 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 98.0364 | 3.97 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 99.0681 | 2.68 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 99.0682 | 8.57 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 99.0685 | 2.02 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 99.0686 | 4.27 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 99.0884 | 2.99 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 99.1044 | 2.22 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 100.0527 | 3.67 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 102.0319 | 4.27 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 102.0324 | 10.19 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 102.0657 | 4.28 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 103.0810 | 0.64 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 103.9940 | 9.36 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 104.0263 | 6.88 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 3-HYDROXYBENZALDEHYDE (M+H)+[-H2O] | 105.0340 | 4.84 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 106.0437 | 5.76 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 106.0783 | 11.74 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 106.0844 | 8.39 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 108.0578 | 6.11 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 108.0578 | 7.04 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 110.0367 | 4.37 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 110.0731 | 7.6 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 110.1098 | 21.82 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 110.9997 | 0.51 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 113.0801 | 3.03 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 113.0834 | 4.35 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 113.0843 | 4.56 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 113.1199 | 13.37 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 113.1200 | 6.52 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 2,5-DIOXOPIPERAZINE (M+H)+ | 115.0510 | 0.67 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 115.0813 | 0.69 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 115.0884 | 1.31 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 117.0788 | 4.4 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 117.0795 | 3.25 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 119.0422 | 2.55 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 120.0436 | 3.08 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 120.0436 | 3.46 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 120.0436 | 5.47 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 121.0503 | 2.68 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 121.0851 | 1.55 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 121.1087 | 2.98 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 122.0351 | 3.91 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 122.0728 | 5.2 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 122.0730 | 8.88 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 123.0313 | 2.77 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 126.0303 | 3.92 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 127.0994 | 6.96 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 127.0994 | 7.33 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 128.0471 | 4.37 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 129.0428 | 2.21 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 129.0429 | 5.32 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 129.0430 | 2.37 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 129.0432 | 6.09 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 129.0787 | 0.54 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 129.1514 | 5.04 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 5-OXOPROLINE (M+H)+ | 130.0500 | 1.21 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 131.0366 | 3.96 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 132.0935 | 7.38 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | ISOLEUCINE (M+H)+ | 132.1000 | 1.6 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 133.0526 | 4.89 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 133.0677 | 3.4 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 134.1089 | 6.67 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 134.1092 | 8.11 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 134.1093 | 6.16 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 134.1094 | 19.96 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 135.0564 | 1.34 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 135.0662 | 4.56 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 135.0684 | 5.32 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 136.0385 | 2.81 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 136.1234 | 7.19 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 136.1245 | 9.05 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 136.1247 | 11.74 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 136.1247 | 15.45 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | HYPOXANTHINE (M+H)+ | 137.0450 | 1.11 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 138.0538 | 5.47 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 138.1033 | 6.74 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 138.1405 | 16.78 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | TRANS-CYCLOHEXANE-1,2-DIOL (M+Na)+ | 139.0730 | 3.77 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 139.0735 | 1.76 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 140.0470 | 4.04 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 140.0834 | 5.2 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 141.0786 | 4.4 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 141.0994 | 2.99 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 141.1505 | 3.93 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 142.0991 | 8.6 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 143.0721 | 3.96 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 143.0770 | 0.7 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 143.0947 | 5.9 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 145.0528 | 6.54 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 145.0736 | 2.42 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 146.0381 | 1.65 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 146.0690 | 5.32 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 4-ACETAMIDOBUTANOIC ACID (M+H)+ | 146.0800 | 1.84 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | SPERMIDINE (M+H)+ | 146.1640 | 0.52 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 147.0683 | 6.9 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 147.1026 | 3.82 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | LYSINE (M+H)+ | 147.1130 | 0.54 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 147.1238 | 3.48 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 148.0156 | 20.92 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 148.0161 | 10.41 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 148.0178 | 5.68 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 148.0190 | 2.58 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 148.0734 | 4.28 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 148.0951 | 8.39 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 148.1246 | 11.99 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 150.0281 | 0.51 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 150.0319 | 4.14 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 150.1178 | 0.64 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 151.0631 | 4.88 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 151.0774 | 3.14 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 152.0260 | 0.51 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 152.0584 | 1.86 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 152.1193 | 6.67 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 152.1193 | 8.11 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 152.1194 | 4.42 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 152.1196 | 7.47 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 153.0752 | 3.06 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 154.0053 | 5.01 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 154.0055 | 4.82 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 154.0055 | 8.81 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 154.0058 | 7.6 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 154.0066 | 2.77 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 154.0587 | 3.93 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 154.1348 | 12.17 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 155.0941 | 7 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 155.1303 | 8.19 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 155.1306 | 13.37 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | L-HISTIDINE (M+H)+ | 156.0770 | 0.6 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 157.0387 | 3.14 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 157.0720 | 3.97 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 158.1408 | 1.61 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 158.1419 | 0.53 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 159.0892 | 1.33 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 159.0893 | 4.34 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 159.1104 | 2.99 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 159.1254 | 13.37 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 159.1258 | 6.52 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 160.0991 | 3.95 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 161.0474 | 4.89 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 161.0487 | 5.76 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 161.0684 | 0.99 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 161.0853 | 0.66 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 162.1248 | 10.24 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 163.0331 | 5.63 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 163.0646 | 1.54 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 164.0834 | 12.13 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 164.0836 | 9.23 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 164.1507 | 3.51 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 165.0452 | 2.56 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 165.0640 | 1.54 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 165.0649 | 1.19 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 165.1148 | 4.85 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 166.0053 | 0.51 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 166.0223 | 3.92 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 166.0490 | 2.59 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 166.0492 | 2.22 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 4-PYRIDOXIC ACID (M+H)+[-H2O] | 166.0510 | 1.92 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 166.1057 | 8.39 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 1-METHYLXANTHINE (M+H)+ | 167.0550 | 2.59 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 168.0889 | 2.86 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 168.1145 | 11.27 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | URIC ACID (M+H)+ | 169.0350 | 1.04 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 169.0373 | 2.78 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | ADIPIC ACID (M+Na)+ | 169.0470 | 3.6 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 169.0529 | 9.75 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 169.0726 | 1.43 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 170.0556 | 4.33 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 170.0560 | 3.6 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 170.0761 | 3.15 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | N(PAI)-METHYL-L-HISTIDINE (M+H)+ | 170.0930 | 0.62 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 170.1303 | 11.75 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 171.0895 | 7.06 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 172.0497 | 4.75 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 172.0705 | 2.27 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 172.1203 | 2.72 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 172.1238 | 2.59 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 173.1046 | 4.27 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 173.1046 | 6.97 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 173.1046 | 7.34 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 173.1048 | 7.9 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 173.1073 | 5.71 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 173.1149 | 1.73 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 173.1164 | 1.59 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 173.1390 | 2.15 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 173.1411 | 8.19 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 174.0417 | 1.83 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 4-QUINOLINECARBOXYLIC ACID #2 (M+H)+ | 174.0550 | 5.02 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 174.0675 | 12.13 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 174.1152 | 3.62 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 174.1387 | 6.84 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 175.0626 | 2.77 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 175.0627 | 6.88 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 176.1555 | 11.05 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 177.0842 | 3.15 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | SEROTONIN (M+H)+ | 177.1030 | 1.81 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | L-HISTIDINE (M+Na)+ | 178.0580 | 0.62 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 179.0804 | 3.75 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 179.0805 | 2.36 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 180.0538 | 4.27 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | HIPPURIC ACID (M+H)+ | 180.0650 | 4.84 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 181.0617 | 1.33 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | THEOPHYLLINE (M+H)+ | 181.0710 | 4.44 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | THEOBROMINE (M+H)+ | 181.0740 | 3.53 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 181.0931 | 2.99 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 182.0574 | 5.66 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 182.0712 | 5.87 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | TYROSINE (M+H)+ | 182.0800 | 1.29 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 182.0917 | 8.85 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 182.1043 | 2.43 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 183.0479 | 1 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 1-METHYLURIC ACID (M+H)+ | 183.0520 | 2.25 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 183.0537 | 4.91 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 183.0891 | 7.08 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 183.1255 | 13.37 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 184.0054 | 3.66 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 184.0163 | 7.19 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | N-METHYL-GLUTAMIC ACID (M+Na)+ | 184.0600 | 1.93 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 184.0911 | 2.95 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 184.1072 | 10.24 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 184.1203 | 3.97 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 184.1213 | 6.35 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 185.1046 | 7.15 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 185.1050 | 7.6 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 186.1249 | 9.9 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 186.1352 | 4.04 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 186.1721 | 4.39 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 187.0265 | 2.5 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 187.1204 | 6.11 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 188.0308 | 2.54 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 188.0627 | 3.71 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 188.0682 | 4.37 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 1-METHYLXANTHINE (M+Na)+ | 189.0390 | 2.52 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 189.0898 | 4.59 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 189.0915 | 0.71 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 189.1340 | 2.75 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 189.1560 | 3.04 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | N6,N6,N6-TRIMETHYL-L-LYSINE (M+H)+ | 189.1600 | 0.61 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | KYNURENIC ACID (M+H)+ | 190.0500 | 4.96 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 191.0189 | 2.78 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 191.1032 | 5.39 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 5-HYDROXYINDOLEACETIC ACID (M+H)+ | 192.0660 | 4.33 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 192.1289 | 0.65 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 193.0467 | 5.66 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 193.0635 | 2.6 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 193.0739 | 6.9 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 193.0755 | 5.76 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | TRANS-3'-HYDROXYCOTININE (M+H)+ | 193.0970 | 1.05 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 194.0704 | 3.23 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 194.1297 | 12.85 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 195.0596 | 6.39 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 195.0764 | 3.46 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 195.0857 | 7.33 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 195.0858 | 7.33 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 195.0867 | 6.96 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 195.0867 | 7.89 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | CAFFEINE (M+H)+ | 195.0880 | 5.96 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 196.0513 | 3.53 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 196.1074 | 6.74 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 196.1205 | 4.82 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 196.1221 | 5.7 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 196.1457 | 15.33 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 1,7-DIMETHYL URIC ACID (M+H)+ | 197.0690 | 4.11 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 1,3-DIMETHYLURIC ACID (M+H)+ | 197.0700 | 3.27 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | SUBERIC ACID (M+Na)+ | 197.0800 | 8.24 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 197.9327 | 0.52 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 198.0870 | 10.19 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 198.1345 | 4.81 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 198.1441 | 5.53 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 198.1616 | 21.82 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 199.1206 | 11.37 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 199.1207 | 12.97 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 200.1044 | 8.9 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 200.1525 | 5.35 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 200.1558 | 15.4 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 201.1011 | 3.32 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 201.1363 | 13.37 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 202.0355 | 4.25 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | HIPPURIC ACID (M+Na)+ | 202.0470 | 4.84 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 202.0737 | 1.8 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 202.1715 | 21.51 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | GLUCOSE (M+Na)+ | 203.0520 | 0.63 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 203.0566 | 5.75 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 203.0791 | 14.38 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 203.0791 | 16.44 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 203.0972 | 0.7 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 203.1516 | 4.94 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 204.0597 | 8.39 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | ACETYLCARNITINE (M+H)+ | 204.1220 | 0.95 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 204.1464 | 0.57 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 204.1870 | 20.63 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 205.0714 | 7.08 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | TRYPTOPHAN (M+H)+ | 205.0970 | 3.66 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 4-PYRIDOXIC ACID (M+Na)+ | 206.0430 | 1.92 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | XANTHURENIC ACID (M+H)+ | 206.0450 | 4.52 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 206.1024 | 3.97 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 206.1252 | 7.08 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 206.9848 | 2.78 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 207.0436 | 1.42 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | L-TRYPTOPHAN-15N2 [ISTD] (M+H)+ | 207.0930 | 3.68 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 208.1174 | 4.04 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 208.1202 | 7.7 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 208.1287 | 3.48 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | KYNURENINE (M+H)+ | 209.0930 | 2.23 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 210.0506 | 4.37 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 210.0997 | 2.84 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 210.1230 | 6.67 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 210.1232 | 10.02 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 210.1233 | 7.48 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 210.1359 | 8.04 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 211.0826 | 4.07 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 1,3,7-TRIMETHYLURIC ACID (M+H)+ | 211.0830 | 5.03 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | N6,N6,N6-TRIMETHYL-L-LYSINE (M+Na)+ | 211.1410 | 0.6 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 3-METHOXYTYROSINE (M+H)+ | 212.0930 | 2.03 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 212.1386 | 14.87 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 213.1359 | 13 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 213.1515 | 5.59 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 214.0949 | 2.09 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 214.1198 | 13.42 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 214.1655 | 4.55 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 214.1665 | 7.1 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | CITRIC ACID (M+Na)+ | 215.0150 | 1.04 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 215.0556 | 6.87 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 216.0399 | 10.42 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 216.1103 | 2.45 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 216.1113 | 1.99 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 216.1204 | 0.71 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 217.0574 | 3.47 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 217.0579 | 3.08 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 217.1134 | 8.54 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 217.1308 | 2.87 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 217.1666 | 6.91 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 217.9845 | 3.03 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 218.0137 | 3.56 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 218.1154 | 8.68 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | PROPIONYLCARNITINE (*) (M+H)+ | 218.1350 | 1.67 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 218.1447 | 0.7 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 218.1656 | 13.65 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 218.1666 | 16.57 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 219.0563 | 2.09 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 219.1249 | 3.35 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 219.1295 | 10.38 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 219.1407 | 3.76 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | ZEATIN [ISTD] (M+H)+ | 220.1180 | 3.99 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | PANTOTHENIC ACID (M+H)+ | 220.1190 | 3.3 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 220.1812 | 14.21 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 221.0670 | 1.49 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 221.0729 | 1.75 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 221.1197 | 2.83 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 221.1736 | 22.9 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 222.0703 | 8.39 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 222.0867 | 7.81 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 222.0868 | 6.18 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 222.1194 | 3.12 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 222.1611 | 15.9 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 223.0597 | 2.42 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 223.0844 | 5.19 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 223.1172 | 3.91 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 223.1207 | 13.82 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 224.1034 | 7.49 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 224.1096 | 8.39 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 224.1758 | 16.48 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 225.0636 | 4.14 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 225.0738 | 0.94 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 226.0170 | 4.38 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 226.0525 | 11.02 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 226.1044 | 0.67 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 226.1183 | 3.1 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 226.1205 | 12.01 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 226.1656 | 1.66 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | TRYPTOPHAN (M+Na)+ | 227.0810 | 3.66 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 227.1878 | 16.4 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 227.1881 | 22.9 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 228.0792 | 10.59 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 228.0982 | 7.35 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 228.1471 | 4.68 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 228.1683 | 5.87 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 229.0048 | 2.12 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 229.0708 | 2.61 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 229.1409 | 6.87 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 229.2400 | 17.6 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 229.9816 | 1.03 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 230.0751 | 1.52 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | N-ACETYL-L-PHENYLALANINE (M+Na)+ | 230.0790 | 7.66 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 230.0981 | 3.47 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 230.1267 | 4.09 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 230.1291 | 1.34 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 230.1514 | 11.99 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 231.0719 | 6.35 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 231.0945 | 6.67 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 231.1104 | 7.35 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 231.1471 | 4.74 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 231.1706 | 2.89 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 231.1831 | 9.06 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 232.0067 | 4.75 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 4-ACETAMINOPHEN SULFATE (M+H)+ | 232.0270 | 2.39 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 232.0715 | 10.88 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | ISO-BUTYRYLCARNITINE (*) (M+H)+ | 232.1550 | 2.82 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 232.1574 | 0.7 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 233.1736 | 0.51 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 234.0981 | 1.36 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 234.1590 | 15.26 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 234.1598 | 13.23 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 236.0110 | 1.87 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 236.0660 | 8.04 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 236.1161 | 3.62 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 237.0998 | 6.96 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 237.1428 | 1.65 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 238.0930 | 2.38 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 238.1295 | 6.6 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 238.1345 | 8.7 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 238.1409 | 4.9 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 238.1543 | 18.25 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 238.9593 | 0.52 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 240.0848 | 2.46 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 240.1105 | 4.86 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 241.0387 | 2.12 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 241.2041 | 22.74 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 242.0411 | 3.92 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | PANTOTHENIC ACID (M+Na)+ | 242.1010 | 3.3 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 242.1095 | 8.87 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 242.1255 | 6.81 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 242.1271 | 6.09 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 242.1284 | 5.66 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 242.1408 | 6.39 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 242.1877 | 16.47 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 243.1472 | 4.22 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 244.0692 | 0.92 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 244.0715 | 14.78 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 244.0737 | 3.62 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 244.1113 | 2.52 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 244.1312 | 12.01 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 244.1425 | 7.18 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 244.1503 | 1.7 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 244.1779 | 6.23 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 245.1430 | 14.15 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 245.1448 | 13.04 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 245.1623 | 4.36 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 245.1624 | 6.55 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 245.1628 | 4.77 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 246.0882 | 2.55 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 246.1152 | 7.04 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 246.1212 | 3.95 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 246.1216 | 2.4 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 246.1216 | 3.65 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 246.1349 | 4.2 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | ISOVALERYLCARNITINE (*) (M+H)+ | 246.1710 | 4.63 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 247.0461 | 4.14 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 247.0859 | 5.32 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 247.0970 | 3.47 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 247.1411 | 1.17 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 247.9709 | 3.91 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 248.0707 | 8.2 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 248.0933 | 8.46 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 248.1501 | 4.56 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 249.0861 | 2.9 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 249.1586 | 14.5 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 250.0417 | 22.14 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 250.0930 | 3.03 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 250.1186 | 11.16 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 250.1210 | 16.99 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 250.1212 | 19.01 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 250.1309 | 4.42 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 251.0798 | 6.08 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 252.1082 | 4.1 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 252.1203 | 4.77 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 252.1313 | 3.47 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 252.9941 | 3.02 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 253.1416 | 5.03 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 253.1536 | 2.33 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 254.0380 | 8.63 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 254.0954 | 7.37 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 254.1128 | 3.09 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 254.1254 | 4.74 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 254.1267 | 3.62 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 254.1534 | 15.58 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 254.1986 | 4.26 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 254.2019 | 15.23 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 254.2028 | 16.57 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 254.2033 | 17.95 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 254.2054 | 21.52 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 254.9326 | 0.51 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 255.0053 | 6.84 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 255.2557 | 22.44 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 256.0927 | 6.27 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 256.1059 | 2.03 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 256.1335 | 3.52 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 256.1342 | 0.69 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 256.1417 | 8.9 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 256.1424 | 8.27 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 256.1501 | 16.06 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 256.1781 | 4.66 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 256.2186 | 19.39 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 256.2188 | 19.5 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 256.2192 | 21.89 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 257.1005 | 1.58 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 257.1708 | 5.53 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 258.0725 | 0.8 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 258.1084 | 5.87 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 258.1756 | 0.68 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 258.1936 | 3.61 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 259.0438 | 3.55 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 259.1415 | 1.79 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 259.1771 | 8.89 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 259.1776 | 6.71 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 259.1781 | 6.28 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 259.1782 | 6.32 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 260.0907 | 1.56 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 260.1168 | 5.37 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 260.1236 | 4.96 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 260.1370 | 4.73 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 260.1373 | 4.43 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 260.1374 | 7.05 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 260.1624 | 1.31 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | HEXANOYLCARNITINE (*) M+ | 260.1860 | 7.13 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 261.0174 | 1.38 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 261.1578 | 2.02 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 262.0263 | 4.75 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 262.1077 | 6.17 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 262.1114 | 5.37 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 262.1331 | 6.35 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 262.1455 | 6.34 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 264.0804 | 7.18 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 264.1094 | 6.09 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 264.1114 | 5.66 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 264.1115 | 5.32 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 265.0954 | 6.67 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 265.1317 | 5.07 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 266.0507 | 0.92 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 266.1140 | 11.77 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 266.1144 | 10.52 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 266.1219 | 6.85 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 266.1244 | 7.18 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 266.1245 | 8.7 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 266.1263 | 8.89 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 266.1561 | 22.5 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 266.9878 | 5.19 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 266.9960 | 5.51 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 268.0513 | 2.69 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 268.0988 | 0.69 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 2'-DEOXYGUANOSINE (M+H)+ | 268.1030 | 1.82 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 268.1061 | 5.11 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 268.1132 | 0.92 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 268.1283 | 8.73 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 268.1406 | 9.03 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 268.1424 | 8.47 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 268.1813 | 15.93 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 268.2014 | 21.53 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 268.9672 | 2.46 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 269.1256 | 3.97 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 270.0669 | 2.7 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 270.0762 | 8.47 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 270.0842 | 1.73 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 270.0852 | 2.16 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 270.1092 | 3.79 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 270.1571 | 9.53 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 270.1583 | 11.64 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 270.1585 | 10.64 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 271.1575 | 12.14 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 271.1606 | 14.59 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 271.1782 | 7.59 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 271.1785 | 7.84 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 271.1789 | 7.09 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 271.1844 | 8.41 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 272.0655 | 2.7 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 272.2133 | 19.27 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 272.2139 | 17.95 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 273.0162 | 16.78 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 273.0327 | 10.41 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 273.1333 | 3.49 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 273.1362 | 6.16 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 273.1766 | 16.33 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 273.1789 | 3.06 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 273.1921 | 10.58 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 273.1937 | 10.9 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 273.1938 | 9.06 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 273.1940 | 8.53 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 273.2662 | 17.31 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 274.0049 | 4.99 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 274.0990 | 6.86 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 274.1030 | 4.77 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 274.1454 | 0.68 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 274.1563 | 15.22 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 274.1615 | 5.5 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 274.2497 | 22.24 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 275.1190 | 6.99 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 275.1343 | 1.67 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 275.1362 | 2.26 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 275.1721 | 5.22 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 275.1730 | 4.17 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 275.1731 | 3.62 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 276.0680 | 1.32 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 276.0946 | 3.1 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 276.1083 | 4.72 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 276.1086 | 3.63 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 276.1254 | 5.18 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 276.1341 | 18.15 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 276.1361 | 14.79 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 276.1364 | 15.77 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 276.2055 | 22.47 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 277.1038 | 4.15 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 277.1145 | 0.92 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 278.0598 | 3.91 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 278.1244 | 8.27 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 278.1265 | 7.02 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 278.1296 | 3.56 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 278.1450 | 3.5 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 278.1510 | 9.23 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 278.1513 | 13.21 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 278.1524 | 21.07 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 280.0128 | 4.16 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 280.0751 | 6.09 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 280.0987 | 5.77 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 280.1058 | 4.45 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 280.1059 | 4.81 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 280.1074 | 6.48 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 280.1087 | 2.88 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 280.1112 | 13.37 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 280.1273 | 3.48 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 280.1280 | 2.98 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 280.1400 | 9.54 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 280.1414 | 5.03 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 281.0929 | 0.7 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 281.1126 | 1.06 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 281.1349 | 3.09 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 281.1964 | 16.4 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 282.0673 | 2.59 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 282.0694 | 4.14 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 282.0892 | 7.18 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 282.0952 | 2.69 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 282.1124 | 8.35 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 282.1174 | 7.04 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 282.1681 | 6.09 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 282.2344 | 15.63 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 282.2347 | 19.51 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 282.2348 | 20.86 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 283.0004 | 1.38 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 283.0566 | 3.56 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 283.1781 | 8.23 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 283.1785 | 7.66 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 283.1845 | 0.93 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 283.2862 | 22.9 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 284.0029 | 7.62 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 284.0778 | 6.17 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 284.1232 | 8.14 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 284.1731 | 13.36 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 284.2504 | 20.14 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 284.2506 | 21.51 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 284.2510 | 19.95 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 285.1183 | 3.06 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 285.1211 | 1.9 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 285.1340 | 4.11 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 285.1940 | 9.39 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 285.1943 | 9.68 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 285.1944 | 10.07 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 286.0937 | 5.33 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 286.1396 | 10.55 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 286.1524 | 4.95 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 286.1551 | 5.47 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 286.1624 | 0.94 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 286.1744 | 0.7 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 286.1925 | 14.95 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 286.1929 | 14.62 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | OCTENOYLCARNITINE (*) M+ | 286.2020 | 9.48 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 286.2139 | 21.82 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 287.0772 | 6.66 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 287.1102 | 1.52 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 287.1115 | 1.12 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 287.1723 | 4.71 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 287.1730 | 4.56 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 287.2095 | 11 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 288.0831 | 4.67 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 288.1626 | 0.7 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 288.1712 | 8.56 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 289.1237 | 2.57 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 289.1271 | 1.97 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 289.1276 | 2.15 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 289.1351 | 4.88 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 289.1521 | 3.83 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 289.1523 | 2.7 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 289.1721 | 2.93 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 289.1884 | 5.27 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 289.2612 | 17.73 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 290.0224 | 3.5 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 290.0732 | 4.67 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 290.1134 | 11.19 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 290.1158 | 13.01 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 290.1241 | 9.02 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 290.1247 | 8.48 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 290.2240 | 17.95 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 291.1504 | 5.95 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 291.1513 | 5.67 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 291.1828 | 12.82 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 291.9838 | 3.4 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 292.0372 | 4.82 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 292.0930 | 7.33 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 292.1294 | 12.05 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 292.1377 | 11.63 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 292.1405 | 10.27 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 292.1531 | 4.65 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 292.1731 | 22.63 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 292.2014 | 21.31 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 294.0787 | 2.83 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 294.0908 | 8.27 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 294.1217 | 5.18 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 294.1572 | 4.24 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 294.1650 | 5.41 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 294.1877 | 22.88 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 295.1286 | 4.33 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 295.1414 | 3.97 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 295.1417 | 3.66 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 296.0813 | 6.85 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 296.1433 | 5.51 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 296.1477 | 5.97 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 296.2325 | 22.35 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 297.0786 | 2.57 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 297.1057 | 2.43 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 297.1070 | 2.82 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 297.1764 | 3.96 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 297.1807 | 0.51 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 297.1938 | 10.52 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 298.0835 | 8.35 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 5'-METHYLTHIOADENOSINE (M+H)+ | 298.0970 | 4.58 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 298.1188 | 15.77 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 298.1458 | 7.25 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 298.2288 | 17.88 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 298.9850 | 0.9 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 299.0971 | 1.04 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 299.1720 | 3.87 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 299.1807 | 5.55 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 299.1930 | 17.59 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 299.1942 | 6.09 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 299.2094 | 11.92 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 299.2095 | 12.74 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 299.2100 | 12.41 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 300.0462 | 6.17 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 300.1093 | 7.47 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 300.1343 | 20.93 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 300.2450 | 20.87 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 300.2458 | 19.51 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 301.1211 | 6.84 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 301.1751 | 3.06 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 301.1877 | 3.92 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 301.1882 | 4.39 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 301.1883 | 4.86 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 301.1885 | 3.77 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 301.1888 | 7.82 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 301.1891 | 6.61 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | GAMMA-LINOLENIC ACID (M+Na)+ | 301.2120 | 22.89 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 301.2266 | 12.86 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | ALLOPREGNANOLONE (M+H)+[-H2O] | 301.2500 | 20.87 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 301.2957 | 21.18 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 302.0453 | 3.91 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 302.0586 | 5.27 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 302.0661 | 5.34 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 302.0792 | 2.87 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 302.0895 | 6.48 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 302.1101 | 2.98 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 302.1508 | 9.11 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 302.2603 | 21.51 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 302.2606 | 19.95 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 303.1227 | 5.96 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 303.1495 | 3.86 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 303.1645 | 4.14 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 303.1777 | 5.47 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 303.2044 | 10.11 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 303.2045 | 8.78 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 303.2051 | 8.16 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 303.2127 | 5.86 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 304.0779 | 2.7 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 304.0889 | 1.48 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 304.0902 | 1.08 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 304.1040 | 7.77 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 304.1505 | 6.09 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 304.1578 | 7.04 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 304.2021 | 13.33 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | OLEIC ACID (M+Na)+ | 305.2440 | 22.61 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 306.0718 | 6.84 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 306.0899 | 9.03 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 306.1149 | 2.2 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 306.1525 | 13.36 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 307.1006 | 3.07 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 307.1441 | 2 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 307.1442 | 2.75 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 307.1831 | 22.51 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 308.1055 | 10.48 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 308.1970 | 21.82 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 308.2302 | 22.4 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 309.1576 | 5.24 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 309.1947 | 11.65 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 309.3018 | 22.96 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 310.0625 | 5.26 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 310.1279 | 5.89 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 310.1378 | 1.2 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 310.2483 | 22.58 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 311.1236 | 3.75 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 311.2098 | 13.87 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 311.2103 | 11.03 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 311.3185 | 23.08 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 312.0784 | 5.11 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 312.1670 | 22.5 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 312.2270 | 21.63 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 313.0852 | 1.79 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 313.1522 | 4.14 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 313.1733 | 5.98 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 313.1955 | 5.55 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 313.2258 | 13.29 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 314.1133 | 14.66 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 314.1180 | 18.43 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 314.1627 | 3.47 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 314.1854 | 21.65 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | DECENOYLCARNITINE (*) (M+H)+ | 314.2340 | 13.86 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 315.0891 | 2.82 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 315.1681 | 5.02 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 315.1685 | 4.62 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 315.1870 | 15.9 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 316.0738 | 7 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 316.1137 | 5.18 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 316.2010 | 21.62 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 316.2396 | 19.13 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 316.2397 | 16.25 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 316.2399 | 18.03 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 316.2403 | 15.03 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 316.2403 | 17.57 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 316.2404 | 15.6 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 316.2407 | 17.71 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 317.1125 | 1.11 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 317.1855 | 5.75 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 317.1925 | 5.51 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 317.2024 | 17.24 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 317.2190 | 7.15 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 317.2192 | 7.32 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 318.0546 | 6.49 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 318.1186 | 8.08 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 318.1193 | 7.02 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 318.1297 | 5.98 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 318.1598 | 6.34 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 318.1845 | 18.23 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 318.1881 | 22.75 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 319.1828 | 18.12 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 320.0577 | 5.55 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 320.0695 | 7.77 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 320.0737 | 1.57 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 320.0750 | 1.93 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 320.1172 | 6.09 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 320.1968 | 10.88 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 320.2043 | 22.96 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 320.2326 | 22.13 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 321.0565 | 1.4 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 321.0665 | 1 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 322.0360 | 6.85 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 322.0553 | 6.81 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 322.1139 | 5.05 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 322.1144 | 4.44 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 322.2191 | 23.23 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 322.2404 | 22.17 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 324.1301 | 8.68 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 324.1534 | 1.27 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 324.1574 | 16.81 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 324.2634 | 22.77 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 325.0304 | 5.26 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 325.0794 | 1.53 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 325.0800 | 1.95 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 325.0829 | 4.03 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 325.1047 | 5.96 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 325.1525 | 4.39 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 325.1609 | 3.07 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 325.1894 | 12.29 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | GLYCEROL MYRISTATE (M+Na)+ | 325.2380 | 22.21 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 326.0317 | 3.92 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 326.0626 | 3.61 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 326.0815 | 3.49 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 326.0877 | 7.52 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 326.1395 | 7.03 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 326.1605 | 3.44 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 326.2140 | 22.88 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 327.0285 | 5.28 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 327.0957 | 1.92 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 327.0962 | 6.23 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 327.1509 | 2.97 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 327.1551 | 5.86 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 327.1785 | 3.99 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 327.2040 | 4.5 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 327.2046 | 9.38 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 327.2411 | 16.08 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 327.8927 | 0.52 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | P-ACETAMIDOPHENYL BETA-D-GLUCURONIDE (M+H)+ | 328.1030 | 2.27 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 328.1525 | 11.75 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 328.2083 | 5.46 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 328.2354 | 23.23 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 328.2372 | 22.43 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 329.1116 | 6.88 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 329.1587 | 5.08 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 329.1634 | 1.99 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 329.1838 | 6.62 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 329.1842 | 6.17 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 329.2199 | 8.64 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 329.2207 | 9.17 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 329.2208 | 11.05 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 329.3296 | 21.73 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 3',5'-CYCLIC AMP (M+H)+ | 330.0620 | 1.98 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001423 | 330.0660 | 3.67 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 330.1110 | 15.29 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 330.1366 | 3.77 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 330.1469 | 9.11 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 330.2192 | 14.21 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 330.2192 | 14.55 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 331.1736 | 5.11 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 331.1836 | 3.44 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 331.1995 | 7.29 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 331.1996 | 7.63 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 331.2352 | 9.92 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 331.2356 | 12.8 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 331.2357 | 10.76 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 331.2845 | 22.96 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 331.3228 | 19.88 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 331.3241 | 20.63 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 332.0686 | 4.33 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 332.1115 | 5.85 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 332.1621 | 17.58 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 332.2341 | 15.05 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 333.1056 | 3.74 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 333.1981 | 3.14 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 333.1986 | 3.48 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 333.2135 | 4.38 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 334.0603 | 5.1 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 334.0713 | 6.24 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 334.0852 | 8.07 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 334.0960 | 5.98 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 334.1501 | 6.26 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 334.2495 | 22.62 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 335.1159 | 8.26 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 335.1372 | 7.71 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 335.2144 | 22.88 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 336.0594 | 5.1 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 336.1606 | 22.75 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 336.1689 | 6.27 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 336.2610 | 22.77 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 337.0803 | 4.09 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 337.0804 | 6.06 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 337.1273 | 4.69 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 337.2256 | 14.16 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 337.3345 | 23.3 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 338.1526 | 21.78 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 338.1581 | 22.75 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 338.1617 | 1.44 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 338.2434 | 22.47 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 338.2796 | 22.88 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 339.0960 | 4.51 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 339.0962 | 7.02 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 339.0979 | 6.68 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 339.0996 | 4.18 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 339.1664 | 6.13 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 339.1683 | 6.51 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 339.2411 | 16.11 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 340.0401 | 1.08 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 340.1663 | 5.61 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 340.1732 | 7.03 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 340.1954 | 22.88 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 340.2227 | 21.94 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 340.2585 | 22.37 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 341.0699 | 5.95 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 341.1531 | 0.7 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 341.2189 | 9.36 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 341.2208 | 8.9 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 341.2292 | 5.17 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 341.2301 | 4.8 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 341.2553 | 17.4 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 341.2570 | 17.22 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 341.2571 | 16.79 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 342.0310 | 3.59 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 342.0562 | 1.57 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 342.0565 | 1.93 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001423 | 342.0934 | 5.02 | Minutes | ST000855 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
